Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability

NCT07053917 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT07053917
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07053917 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability
Lead sponsor
Johns Hopkins University
Phase
Phase 1
Overall status
Recruiting
Start date
February 9, 2026
Completion date
March 31, 2027
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic stroke, hemiparesis after stroke, hemiplegia and hemiparesis, hemiplegia and/or hemiparesis following stroke, hemiplegia following ischemic stroke, intracerebral haemorrhage, intracerebral haemorrhage (ich), intracerebral hemorrhage basal ganglia, ischemic stroke, ischemic stroke and hemorrhagic stroke, middle cerebral artery stroke, stroke